Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis

Chronic obstructive pulmonary disease (COPD) is at present the third leading cause of death in the world. Long-acting muscarinic antagonist (LAMA) is widely used as a bronchodilator in patients with COPD. However, there is controversy concerning their cardiovascular safety. This meta-analysis aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuchu, Zhang, Meng, Wang, Yalei, Xiong, Huaiyu, Huang, Qiangru, Shuai, Tiankui, Liu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639957/
https://www.ncbi.nlm.nih.gov/pubmed/34362778
http://dx.doi.org/10.1136/jim-2021-001931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639957/
https://www.ncbi.nlm.nih.gov/pubmed/34362778
http://dx.doi.org/10.1136/jim-2021-001931

Ejemplares similares